Skip to content
All Podcasts – Lifestyle
Author:
DELOITTE GLOBAL SERVICES LIMITED
OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors
August 18, 2026
/C O R R E C T I O N — Deloitte/
March 12, 2026
Deloitte is recognized as a Leader and Star Performer in Everest Group’s Private Equity Services PEAK Matrix® Assessment 2026, two years in a row
March 12, 2026
Deloitte unveils physical AI solutions built with NVIDIA Omniverse Libraries to help accelerate industrial transformation
March 5, 2026